[Asia Economy Reporter Lee Seon-ae] Hugel announced on the 1st that it has applied for product approval from the U.S. Food and Drug Administration (FDA) for Botulax 50 units and 100 units.
Hugel stated, "We expect to confirm the efficacy and safety of Botulax (product name Letibotulinum Toxin A 50/100unit) for the improvement of moderate to severe glabellar lines," and added, "We plan to launch the product in the U.S. after obtaining product approval."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

